Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.100
-0.015 (-1.35%)
May 9, 2025, 10:29 AM - Market open
Standard BioTools Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -132.76 | -138.89 | -74.66 | -190.1 | -59.24 | -53.02 | Upgrade
|
| Depreciation & Amortization | 15.84 | 16.86 | 15.18 | 15.03 | 3.65 | 6.03 | Upgrade
|
| Other Amortization | - | - | - | - | 12.54 | 12.46 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.21 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 3.53 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -5.62 | -7.44 | -1.26 | -0.67 | - | - | Upgrade
|
| Stock-Based Compensation | 29.13 | 31.73 | 13.12 | 14.88 | 16.1 | 14.45 | Upgrade
|
| Other Operating Activities | 4.44 | -16.53 | 6.3 | 86.56 | 2.81 | 2.04 | Upgrade
|
| Change in Accounts Receivable | 6.26 | 8.97 | -2.99 | 1.06 | 6.73 | -7.63 | Upgrade
|
| Change in Inventory | -7.37 | -9.88 | -4.91 | -8.47 | -4.78 | -8.64 | Upgrade
|
| Change in Accounts Payable | -3.27 | -12.98 | 1.62 | -2.78 | 1.28 | 3.36 | Upgrade
|
| Change in Unearned Revenue | -2.92 | -4.14 | 0.88 | -3.47 | -3.21 | 2.11 | Upgrade
|
| Change in Other Net Operating Assets | -15 | -11.17 | 3.43 | -4.95 | -19.95 | 13.21 | Upgrade
|
| Operating Cash Flow | -111.26 | -143.45 | -43.29 | -89.37 | -44.06 | -15.42 | Upgrade
|
| Capital Expenditures | -12.63 | -8.36 | -2.83 | -3.83 | -13.26 | -12.72 | Upgrade
|
| Cash Acquisitions | -1.39 | 278.65 | - | - | - | -5.15 | Upgrade
|
| Investment in Securities | 73.74 | 92.88 | 23.07 | -84.3 | - | 36.81 | Upgrade
|
| Other Investing Activities | - | - | - | - | 1.32 | 21.04 | Upgrade
|
| Investing Cash Flow | 59.72 | 363.17 | 20.24 | -88.13 | -11.95 | 39.98 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 6.84 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 25 | 10 | - | Upgrade
|
| Total Debt Issued | - | - | - | 25 | 16.84 | - | Upgrade
|
| Long-Term Debt Repaid | - | -63.19 | -2.08 | -6.84 | -0.5 | - | Upgrade
|
| Net Debt Issued (Repaid) | -55 | -63.19 | -2.08 | 18.16 | 16.34 | - | Upgrade
|
| Issuance of Common Stock | 2 | 2.07 | 0.83 | 0.92 | 1.49 | 22 | Upgrade
|
| Repurchase of Common Stock | -29.93 | -40.95 | -5.55 | -0.77 | -1.79 | -0.46 | Upgrade
|
| Other Financing Activities | - | -0.55 | - | -12.55 | -0.08 | -0.68 | Upgrade
|
| Financing Cash Flow | -82.93 | -102.62 | -6.81 | 230.76 | 15.96 | 20.86 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.41 | -0.79 | 0.03 | -0.4 | -0.02 | 0.39 | Upgrade
|
| Net Cash Flow | -134.87 | 116.32 | -29.83 | 52.86 | -40.07 | 45.8 | Upgrade
|
| Free Cash Flow | -123.89 | -151.81 | -46.12 | -93.2 | -57.33 | -28.13 | Upgrade
|
| Free Cash Flow Margin | -73.01% | -87.03% | -43.37% | -95.15% | -43.90% | -20.37% | Upgrade
|
| Free Cash Flow Per Share | -0.33 | -0.43 | -0.58 | -1.19 | -0.76 | -0.39 | Upgrade
|
| Cash Interest Paid | 2.9 | 3.09 | 3.82 | 3.49 | 3.15 | 3.09 | Upgrade
|
| Cash Income Tax Paid | 0.57 | 0.61 | 0.8 | 0.31 | 2.09 | 0.52 | Upgrade
|
| Levered Free Cash Flow | -59.87 | -71.55 | -9.27 | -39.97 | -31.59 | -5.31 | Upgrade
|
| Unlevered Free Cash Flow | -58.44 | -69.48 | -6.42 | -37.26 | -29.82 | -3.62 | Upgrade
|
| Change in Net Working Capital | 11.84 | 25.49 | -7.51 | 1.42 | 6.07 | -8.6 | Upgrade
|
Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.